ruboxistaurin has been researched along with Reperfusion Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Jing, H; Li, Z; Liu, K; Ning, S; Tian, X; Wang, G; Xu, W; Yao, J; Zhang, F | 1 |
Cao, F; Guo, W; Hwang, A; Si, R; Sun, D; Wang, H; Wei, L; Yin, Z; Yuan, Y; Zhang, R; Zhang, Y | 1 |
2 other study(ies) available for ruboxistaurin and Reperfusion Injury
Article | Year |
---|---|
Blockade of PKCĪ² protects against remote organ injury induced by intestinal ischemia and reperfusion via a p66shc-mediated mitochondrial apoptotic pathway.
Topics: Animals; Apoptosis; Caspase 3; Cytochromes c; Glutathione; Indoles; Intestines; Liver; Lung; Male; Maleimides; Mice, Inbred ICR; Mitochondria; Protective Agents; Protein Kinase C beta; Protein Kinase Inhibitors; Reperfusion Injury; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1 | 2014 |
A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats.
Topics: Actins; Animals; Apoptosis; Diabetes Mellitus, Experimental; Down-Regulation; Electric Impedance; Endothelial Cells; Glucose; Indoles; Lim Kinases; Male; Maleimides; Microvessels; Myocardium; Protective Agents; Protein Kinase C; Protein Kinase C beta; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2010 |